The trouble with antidepressants: why the evidence overplays benefits and underplays risks—an essay by John B Warren
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The trouble with antidepressants: why the evidence overplays benefits and underplays risks—an essay by John B Warren
Authors
Keywords
-
Journal
BMJ-British Medical Journal
Volume -, Issue -, Pages m3200
Publisher
BMJ
Online
2020-09-03
DOI
10.1136/bmj.m3200
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TEMPORARY REMOVAL: The war on antidepressants: What we can, and can't conclude, from the systematic review of antidepressant withdrawal effects by Davies and Read
- (2019) Sameer Jauhar et al. ADDICTIVE BEHAVIORS
- Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class
- (2019) Jean Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Guidelines for Statistical Reporting in the Journal
- (2019) David Harrington et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anticholinergic Drug Exposure and the Risk of Dementia
- (2019) Carol A. C. Coupland et al. JAMA Internal Medicine
- Dose Increase Versus Unchanged Continuation of Antidepressants After Initial Antidepressant Treatment Failure in Patients With Major Depressive Disorder
- (2018) Lena Rink et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
- (2018) Andrea Cipriani et al. LANCET
- Pop a million happy pills? Antidepressants, nuance, and the media
- (2018) Kate Adlington BMJ-British Medical Journal
- Pop a million happy pills? Antidepressants, nuance, and the media
- (2018) Kate Adlington BMJ-British Medical Journal
- TEMPORARY REMOVAL: A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?
- (2018) James Davies et al. ADDICTIVE BEHAVIORS
- Network meta-analysis of antidepressants
- (2018) Kim Boesen et al. LANCET
- Network meta-analysis of antidepressants
- (2018) Irving Kirsch et al. LANCET
- Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource
- (2018) Ben Goldacre et al. BMJ-British Medical Journal
- Composite endpoints and the distortion of risk-benefit analysis
- (2016) John B. Warren BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Meta-analyses with industry involvement are massively published and report no caveats for antidepressants
- (2016) Shanil Ebrahim et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences
- (2015) Joanna Moncrieff et al. Contemporary Clinical Trials
- What does the HAMD mean?
- (2013) Stefan Leucht et al. JOURNAL OF AFFECTIVE DISORDERS
- Symmetrical analysis of risk-benefit
- (2012) John B. Warren et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications
- (2011) Ni A. Khin et al. JOURNAL OF CLINICAL PSYCHIATRY
- Tardive dysphoria: The role of long term antidepressant use in-inducing chronic depression
- (2011) Rif S. El-Mallakh et al. MEDICAL HYPOTHESES
- Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
- (2008) Erick H. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started